Researchers Develop New Duo-Targeting Drug for Aggressive Leukemias (UF Health)
UF Health Cancer Institute researchers have created a novel drug that effectively killed aggressive leukemia cells by targeting two proteins that promote the cancer’s growth.
With an Eye on Color, ChE’s Peng Jiang Seeks Easier Ways To Detect Harmful Chemicals (UF Department of Chemical Engineering)
Peng Jiang, Ph.D., a professor in UF’s Department of Chemical Engineering, or ChE, recently received a three-year National Science Foundation research grant that will help develop a new generation of non-mechanical, low-cost, reusable “smart” sensors that will visually detect hazardous chemicals by changing colors.
UF Researchers Join New NSF-Funded AI Institute To Transform Rehabilitation and Health Care (UF News)
Researchers from the University of Florida are playing a key role in a new national effort to advance rehabilitation and health care through artificial intelligence.
New Study Reveals Potential Atmosphere on Rocky Planet of Nearby Star (UF News)
Nearly a decade after discovering LHS 1140b, a rocky exoplanet in the habitable zone of a nearby low-mass star, a new study reveals the object may have its own atmosphere.
A Clear Vision: Researchers Develop Robotic Surgical Cameras That Mimic the Human Eye (UF News)
Researchers at the University of Florida have developed a soft, magnetically driven, AI-powered, nature-inspired robotic device that operates much like the human eye — blinking, using tears to clean away contaminants and automatically moving around to get the best view.
UF Developing AI Tools To Predict Flesh-Eating Waterborne Threats (The Gainesville Sun)
A new UF-led initiative will create forecasting tools that can anticipate health risks linked to environmental conditions, providing advance warnings similar to the way weather forecasting helps communities prepare for storms and other hazards.
Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis (Globe Newswire)
UF startup Atsena Therapeutics has announced that the first patient has been dosed in the Phase 3 pivotal cohort of the LIGHTHOUSE trial evaluating ATSN-201 for the treatment of X-linked retinoschisis.
Retinal Photographs Can Help Predict Alzheimer’s Disease Risk Factors (UF News)
UF researcher Ruogu Fang, Ph.D., is using routine retinal photos, already common in eye exams, to flag risk factors linked to Alzheimer’s years before symptoms appear.
TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers (PR Newswire)
TuHURA Biosciences, formed by CohBar and Morphogenesis, a UF startup, announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the study of its TBS-2025 VISTA inhibiting antibody for the treatment of molecularly defined subsets of AML and other blood related cancers.
UF Health Jacksonville Trial Explores DNA-Guided Treatment for Acid Reflux (UF Health)
UF-led clinical trial will test whether genotype-guided dosing of acid reflux medications can improve treatment outcomes for patients with erosive esophagitis.